COVID-19 vaccinations summary

Second Boosters Administered 1,033,181
Total Doses Administered 12,965,689
First Boosters Administered 2,773,405
Percentage of 12+ who have completed primary course 86.7%
Percentage of eligible 50+ who have received second booster 56.7%
Percentage of eligible 18+ who have received first booster 74.1%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

The person view includes all people that are currently alive and in the latest Health Service User (HSU) population. The current HSU in use is the financial year 2022/23 HSU (FY2022/23 HSU). The HSU is an estimate of the population using the health system in New Zealand. A person is included in the HSU if they use health services (including births and deaths) in the reference period, or are enrolled in a primary health organisation (PHO) during the reference period. The reference period for the FY2022/23 HSU is: 1/7/2022 to 30/6/2023.

Total vaccinations

  Vaccinations last week Cumulative total
First dose 369 4,042,016
Second dose 44 3,986,780
Booster 1 132 2,773,405
Booster 2 932 1,033,181
Booster 3+ 5,600 698,753
Paediatric First Dose 11 272,289
Paediatric Second Dose 16 158,891
Infant First Dose 0 166
Infant Second Dose 0 126
Infant Third Dose 0 82
Total doses 7,104 12,965,689

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Friday 09 February 2024.
  • Vaccinations last week:  Over the 7 days up to and including Friday 09 February 2024.

Booster breakdowns

Booster counts by ethnicity

Ethnicity

Booster 1 (16-17)

Booster 1 (18+)

Booster 2 (50+)

Māori

719

252,274

64,090

Pacific Peoples

486

147,014

28,188

Asian

1,447

439,896

63,527

European/Other

4,450

1,799,601

685,718

Unknown

14

12,380

3,521

Total

7,116

2,651,165

845,044

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
18 to 34 162,625 38,483 23.7%
35 to 49 619,429 121,450 19.6%
50 to 64 722,070 290,268 40.2%
65+ 768,793 554,776 72.2%


This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings. 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation